tiprankstipranks

Elliot Norry Insider Profile

4 Followers
Elliot Norry, CMO at Adaptimmune Therapeutics, holds 19.26K shares in Adaptimmune Therapeutics (Ticker: ADAP).
tipranks
Elliot Norry

Elliot Norry
Adaptimmune Therapeutics (ADAP)
CMO

Not Ranked
Elliot Norry has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$23K
100.00%
A breakdown of Elliot Norry's holdings

Insider Roles

Adaptimmune Therapeutics
(ADAP)
CMO
Roles that Elliot Norry holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Elliot Norry

Elliot Norry's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Adaptimmune Therapeutics
Jan 17, 2024
CMO
Uninformative Sell
14.05K
$22.53K
Elliot Norry has not reported any informative transactions for ADAP, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jan 15, 2020
Uninformative Sell
$4.67K
-
$5.13
Jan 05, 2021
Uninformative Sell
$4.50K
-
$5.32
Jan 12, 2021
Uninformative Sell
$5.17K
-
$6.15
Jan 19, 2021
Uninformative Sell
$11.95K
-
$5.66
Jan 05, 2022
Uninformative Sell
$3.45K
-
$4.06
List of latest transactions for each holding click on a transaction to see Elliot Norry's performance on stock

Elliot Norry insider profile FAQ

What is the percentage of profitable transactions made by Elliot Norry?
The percentage of profitable transactions made by Elliot Norry is ―.
    What is the average return per transaction made by Elliot Norry?
    The average return per transaction made by Elliot Norry is ―.
      What stocks does Elliot Norry hold?
      Elliot Norry holds: ADAP stocks.
        What was Elliot Norry’s latest transaction?
        Elliot Norry latest transaction was an Uninformative Sell of $14.05K.
          What was Elliot Norry's most profitable transaction?
          Elliot Norry’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Elliot Norry's role in Adaptimmune Therapeutics?
            Elliot Norry's role in Adaptimmune Therapeutics is CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.